Single Blind, Randomized, Comparative, Multicentre Clinical Trial of the Immunogenicity and Safety of Vaccine Against Tetanus and Diphtheria.
Condition: Diphtheria; Tetanus; Vaccine; Booster Intervention: Biological: Clodivac/Td Impfstoff Merieux Sponsor: IBSS Biomed S.A. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 29, 2022 Category: Research Source Type: clinical trials
A Study to Evaluate Safety, Reactogenicity, and Immune Response of GVGH iNTS-TCV Vaccine Against Invasive Nontyphoidal Salmonella and Typhoid Fever
Condition: Salmonella Infections Interventions: Biological: Invasive nontyphoidal Salmonella-typhoid conjugate vaccine (iNTS-TCV) low dose; Biological: Invasive nontyphoidal Salmonella-generalized modules for membrane antigens vaccine (iNTS-GMMA) low dose; Biological: Typhoid conjugate vaccine (TCV) low dose; Biological: Invasive non typhoidal Salmonella-typhoid conjugate vaccine (iNTS-TCV) full dose; Biological: Invasive nontyphoidal Salmonella-generalized modules for membrane antigens vaccine (iNTS-GMMA) full dose; Biological: Typhoid conjugate vaccine (TCV) full dose; Biological: GSK's Meningoco...
Source: ClinicalTrials.gov - July 29, 2022 Category: Research Source Type: clinical trials
Single Blind, Randomized, Comparative, Multicentre Clinical Trial of the Immunogenicity and Safety of Vaccine Against Tetanus and Diphtheria.
Condition: Diphtheria; Tetanus; Vaccine; Booster Intervention: Biological: Clodivac/Td Impfstoff Merieux Sponsor: IBSS Biomed S.A. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 29, 2022 Category: Research Source Type: clinical trials
A Study to Evaluate Safety, Reactogenicity, and Immune Response of GVGH iNTS-TCV Vaccine Against Invasive Nontyphoidal Salmonella and Typhoid Fever
Condition: Salmonella Infections Interventions: Biological: Invasive nontyphoidal Salmonella-typhoid conjugate vaccine (iNTS-TCV) low dose; Biological: Invasive nontyphoidal Salmonella-generalized modules for membrane antigens vaccine (iNTS-GMMA) low dose; Biological: Typhoid conjugate vaccine (TCV) low dose; Biological: Invasive non typhoidal Salmonella-typhoid conjugate vaccine (iNTS-TCV) full dose; Biological: Invasive nontyphoidal Salmonella-generalized modules for membrane antigens vaccine (iNTS-GMMA) full dose; Biological: Typhoid conjugate vaccine (TCV) full dose; Biological: GSK's Meningoco...
Source: ClinicalTrials.gov - July 29, 2022 Category: Research Source Type: clinical trials
Single Blind, Randomized, Comparative, Multicentre Clinical Trial of the Immunogenicity and Safety of Vaccine Against Tetanus and Diphtheria.
Condition: Diphtheria; Tetanus; Vaccine; Booster Intervention: Biological: Clodivac/Td Impfstoff Merieux Sponsor: IBSS Biomed S.A. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 29, 2022 Category: Research Source Type: clinical trials
A Study to Evaluate Safety, Reactogenicity, and Immune Response of GVGH iNTS-TCV Vaccine Against Invasive Nontyphoidal Salmonella and Typhoid Fever
Condition: Salmonella Infections Interventions: Biological: Invasive nontyphoidal Salmonella-typhoid conjugate vaccine (iNTS-TCV) low dose; Biological: Invasive nontyphoidal Salmonella-generalized modules for membrane antigens vaccine (iNTS-GMMA) low dose; Biological: Typhoid conjugate vaccine (TCV) low dose; Biological: Invasive non typhoidal Salmonella-typhoid conjugate vaccine (iNTS-TCV) full dose; Biological: Invasive nontyphoidal Salmonella-generalized modules for membrane antigens vaccine (iNTS-GMMA) full dose; Biological: Typhoid conjugate vaccine (TCV) full dose; Biological: GSK's Meningoco...
Source: ClinicalTrials.gov - July 29, 2022 Category: Research Source Type: clinical trials
Single Blind, Randomized, Comparative, Multicentre Clinical Trial of the Immunogenicity and Safety of Vaccine Against Tetanus and Diphtheria.
Condition: Diphtheria; Tetanus; Vaccine; Booster Intervention: Biological: Clodivac/Td Impfstoff Merieux Sponsor: IBSS Biomed S.A. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 29, 2022 Category: Research Source Type: clinical trials
A Study to Evaluate Safety, Reactogenicity, and Immune Response of GVGH iNTS-TCV Vaccine Against Invasive Nontyphoidal Salmonella and Typhoid Fever
Condition: Salmonella Infections Interventions: Biological: Invasive nontyphoidal Salmonella-typhoid conjugate vaccine (iNTS-TCV) low dose; Biological: Invasive nontyphoidal Salmonella-generalized modules for membrane antigens vaccine (iNTS-GMMA) low dose; Biological: Typhoid conjugate vaccine (TCV) low dose; Biological: Invasive non typhoidal Salmonella-typhoid conjugate vaccine (iNTS-TCV) full dose; Biological: Invasive nontyphoidal Salmonella-generalized modules for membrane antigens vaccine (iNTS-GMMA) full dose; Biological: Typhoid conjugate vaccine (TCV) full dose; Biological: GSK's Meningoco...
Source: ClinicalTrials.gov - July 29, 2022 Category: Research Source Type: clinical trials
Single Blind, Randomized, Comparative, Multicentre Clinical Trial of the Immunogenicity and Safety of Vaccine Against Tetanus and Diphtheria.
Condition: Diphtheria; Tetanus; Vaccine; Booster Intervention: Biological: Clodivac/Td Impfstoff Merieux Sponsor: IBSS Biomed S.A. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 29, 2022 Category: Research Source Type: clinical trials
A Study to Evaluate Safety, Reactogenicity, and Immune Response of GVGH iNTS-TCV Vaccine Against Invasive Nontyphoidal Salmonella and Typhoid Fever
Condition: Salmonella Infections Interventions: Biological: Invasive nontyphoidal Salmonella-typhoid conjugate vaccine (iNTS-TCV) low dose; Biological: Invasive nontyphoidal Salmonella-generalized modules for membrane antigens vaccine (iNTS-GMMA) low dose; Biological: Typhoid conjugate vaccine (TCV) low dose; Biological: Invasive non typhoidal Salmonella-typhoid conjugate vaccine (iNTS-TCV) full dose; Biological: Invasive nontyphoidal Salmonella-generalized modules for membrane antigens vaccine (iNTS-GMMA) full dose; Biological: Typhoid conjugate vaccine (TCV) full dose; Biological: GSK's Meningoco...
Source: ClinicalTrials.gov - July 29, 2022 Category: Research Source Type: clinical trials
Single Blind, Randomized, Comparative, Multicentre Clinical Trial of the Immunogenicity and Safety of Vaccine Against Tetanus and Diphtheria.
Condition: Diphtheria; Tetanus; Vaccine; Booster Intervention: Biological: Clodivac/Td Impfstoff Merieux Sponsor: IBSS Biomed S.A. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 29, 2022 Category: Research Source Type: clinical trials
A Study to Evaluate Safety, Reactogenicity, and Immune Response of GVGH iNTS-TCV Vaccine Against Invasive Nontyphoidal Salmonella and Typhoid Fever
Condition: Salmonella Infections Interventions: Biological: Invasive nontyphoidal Salmonella-typhoid conjugate vaccine (iNTS-TCV) low dose; Biological: Invasive nontyphoidal Salmonella-generalized modules for membrane antigens vaccine (iNTS-GMMA) low dose; Biological: Typhoid conjugate vaccine (TCV) low dose; Biological: Invasive non typhoidal Salmonella-typhoid conjugate vaccine (iNTS-TCV) full dose; Biological: Invasive nontyphoidal Salmonella-generalized modules for membrane antigens vaccine (iNTS-GMMA) full dose; Biological: Typhoid conjugate vaccine (TCV) full dose; Biological: GSK's Meningoco...
Source: ClinicalTrials.gov - July 29, 2022 Category: Research Source Type: clinical trials
Single Blind, Randomized, Comparative, Multicentre Clinical Trial of the Immunogenicity and Safety of Vaccine Against Tetanus and Diphtheria.
Condition: Diphtheria; Tetanus; Vaccine; Booster Intervention: Biological: Clodivac/Td Impfstoff Merieux Sponsor: IBSS Biomed S.A. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 29, 2022 Category: Research Source Type: clinical trials
Study to Evaluate the Immunogenicity and Safety of LBVD (Hexavalent Vaccine; DTwP-HepB-IPV-Hib Vaccine), Given to Healthy Infants at Primary Series
Conditions: Diphtheria; Tetanus; Pertussis; Hepatitis B; Poliomyelitis; Haemophilus Influenzae Type B Infection Interventions: Biological: LBVD (Hexavalent vaccine); Biological: Pentavalent vaccine and Inactivated Polio vaccine (Sabin strains) Sponsor: LG Chem Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 14, 2022 Category: Research Source Type: clinical trials
